Posted May 12, 2025
As we continue to navigate the long-term effects of COVID-19, one condition that has raised concerns is myocarditis – an inflammation of the heart muscle. While rare, COVID-19-related myocarditis has been observed at significantly higher rates compared to pre-pandemic levels. Here’s what you need to know about how COVID-19 can affect the heart, its symptoms, risks and how to protect yourself.
When you have myocarditis, your heart muscle becomes inflamed, which can interfere with its ability to pump blood effectively. This can lead to a range of complications depending on the severity of the inflammation, such as:
Viral infections, including COVID-19, are a leading cause of myocarditis worldwide. The COVID-19 virus can enter heart cells, triggering inflammation and potential damage. In some cases, the immune system overreacts, releasing too many defense chemicals, which can make the inflammation worse.
Myocarditis from COVID-19 has symptoms similar to other forms of viral myocarditis. These can include chest pain and pressure, shortness of breath, palpitations, fatigue and fainting.
Myocarditis can develop days to months after a COVID-19 infection, with cases often detected between one to six months post-infection. While some cases may be asymptomatic, others may require medical intervention. Diagnosis typically involves an evaluation of symptoms, ECG tests, cardiac imaging (such as an MRI) and blood tests.
Currently, myocarditis from COVID-19 is treated the same way as other cases of myocarditis, following standard medical guidelines. This may include:
• Medications for heart function and reducing inflammation
• Rest and activity modification
• Individualized treatment approaches depending on symptom severity
While some patients recover without complications, more severe cases may require hospitalization and close monitoring.
Yes, myocarditis can recur, particularly in those with a history of viral myocarditis. People who have had myocarditis are generally advised to wait at least six months before receiving a COVID-19 vaccination to reduce the risk of recurrence.
Myocarditis after a COVID-19 vaccination is rare. When it does occur, it most often affects young males (ages 12–39) after the second dose. Studies show these cases are usually mild and short-lived, with most people making a full recovery.
What’s more, the benefits of vaccination far outweigh the risks – it helps prevent severe COVID-19 complications, including heart inflammation, and even offers heart-protective benefits. While vaccine-related myocarditis is typically mild, myocarditis from COVID-19 itself can be much more serious.
While myocarditis remains a rare condition, understanding the risks associated with COVID-19 and its vaccines is crucial. If you have concerns about myocarditis, whether from infection or vaccination, talk with your healthcare provider. Being vigilant about heart health and getting vaccinated can help minimize risks and keep you protected in the long run.
Gabriela Orasanu, M.D., is director of advanced heart failure at Summa Health. To learn more about our heart and vascular services, visit summahealth.org/heart.
Receive the Summa Health eNewsletter for the latest health tips, advice and updates.